MORDOR II Burkina Faso: Longitudinal Trial

Clinical trial NCT03676751 · COMPLETED

Trial details

NCT number: NCT03676751
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Child Growth Diversity of Microbiome Child Mortality Resistance Bacterial

Start date: 2019-10-10
Primary completion: 2020-07-06
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.